首页> 美国卫生研究院文献>Arrhythmia Electrophysiology Review >Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
【2h】

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation

机译:用于检测和治疗心房颤动的人工智能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AF is the most common clinically relevant cardiac arrhythmia associated with multiple comorbidities, cardiovascular complications (e.g. stroke) and increased mortality. As artificial intelligence (AI) continues to transform the practice of medicine, this review article highlights specific applications of AI for the screening, diagnosis and treatment of AF. Routinely used digital devices and diagnostic technology have been significantly enhanced by these AI algorithms, increasing the potential for large-scale population-based screening and improved diagnostic assessments. These technologies have similarly impacted the treatment pathway of AF, identifying patients who may benefit from specific therapeutic interventions. While the application of AI to the diagnostic and therapeutic pathway of AF has been tremendously successful, the pitfalls and limitations of these algorithms must be thoroughly considered. Overall, the multifaceted applications of AI for AF are a hallmark of this emerging era of medicine.
机译:AF 是最常见的临床相关心律失常,与多种合并症、心血管并发症(例如 中风)和死亡率增加。随着人工智能 (AI) 不断改变医学实践,这篇综述文章重点介绍了人工智能在 AF 筛查、诊断和治疗中的具体应用。这些 AI 算法显著增强了常规使用的数字设备和诊断技术,增加了大规模基于人群的筛查和改进诊断评估的潜力。这些技术同样影响了 AF 的治疗途径,确定了可能从特定治疗干预中受益的患者。虽然人工智能在 AF 诊断和治疗途径中的应用取得了巨大成功,但必须彻底考虑这些算法的陷阱和局限性。总体而言,AI 在 AF 中的多方面应用是这个新兴医学时代的标志。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号